See other bills
under the
same topic
        PRIOR PRINTER'S NO. 211                       PRINTER'S NO. 1529

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 185 Session of 2007


        INTRODUCED BY SOLOBAY, BELFANTI, CALTAGIRONE, CAPPELLI, CARROLL,
           COHEN, CREIGHTON, DALEY, FABRIZIO, GALLOWAY, GINGRICH,
           GRUCELA, HERSHEY, HORNAMAN, KOTIK, KULA, MAHONEY, MANN,
           MELIO, M. O'BRIEN, PALLONE, PETRARCA, REED, REICHLEY,
           SABATINA, SCAVELLO, STABACK, SURRA, TANGRETTI, WALKO AND
           LONGIETTI, FEBRUARY 1, 2007

        AS REPORTED FROM COMMITTEE ON HEALTH AND HUMAN SERVICES, HOUSE
           OF REPRESENTATIVES, AS AMENDED, MAY 8, 2007

                                     AN ACT

     1  Providing for prescription drug redistribution within health
     2     care and State GOVERNMENTAL correctional facilities.           <--

     3     The General Assembly of the Commonwealth of Pennsylvania
     4  hereby enacts as follows:
     5  Section 1.  Short title.
     6     This act shall be known and may be cited as the Prescription
     7  Drug Redistribution Act.
     8  Section 2.  Definitions.
     9     The following words and phrases when used in this act shall
    10  have the meanings given to them in this section unless the
    11  context clearly indicates otherwise:
    12     "Crediting fee."  The fee imposed by a licensed pharmacist
    13  for accepting any portion of an unused, returned prescription,
    14  which shall be approved by the Pennsylvania Fair Drug Pricing
    15  Board. The crediting fee shall be not less than $3.50 and not


     1  more than $7.50 for any prescription.
     2     "FDA."  The Federal Food and Drug Administration.
     3     "Health care facility."  Any of the following, regardless of
     4  whether the facility is for profit, nonprofit or governmental:
     5         (1)  A general or specific hospital, including State
     6     centers for the mentally retarded and psychiatric hospitals.
     7         (2)  Skilled nursing facilities.
     8         (3)  Intermediate care facilities.
     9         (4)  Personal care homes.
    10     "Hospital."  An institution licensed or regulated as a
    11  hospital by the Department of Health or the Department of Public
    12  Welfare or a facility owned or operated by the Federal
    13  Government and accredited by the Joint Commission on
    14  Accreditation of Hospitals as a hospital.
    15     "Vendor pharmacy."  A licensed pharmacy that is located on     <--
    16  the premises of a health care facility or State correctional
    17  facility and dispenses medications exclusively to the health
    18  care facility or State correctional facility in which it is
    19  located. THE LICENSED PHARMACY OF ORIGIN.                         <--
    20  Section 3.  Return to and repackaging by vendor pharmacy.
    21     (a)  General.--Each health care facility or State              <--
    22  GOVERNMENTAL correctional facility shall return to the vendor     <--
    23  pharmacy, for initial repackaging by that vendor pharmacy and
    24  redistribution to that health care facility or State              <--
    25  GOVERNMENTAL correctional facility, drug products which are:      <--
    26         (1)  prescription drug products that are not controlled
    27     substances;
    28         (2)  sealed in individually packaged units;
    29         (3)  returned to the vendor pharmacy at least 90 days
    30     prior to the expiration of the recommended period of shelf
    20070H0185B1529                  - 2 -     

     1     life for the purpose of redispensing such drug products; and
     2         (4)  oral and parenteral medication in single-dose sealed
     3     containers approved by the FDA, topical or inhalant drug
     4     products in units of use containers approved by the FDA or
     5     parenteral medications in multiple-dose sealed containers
     6     approved by the FDA from which no doses have been withdrawn.
     7     (b)  Return to vendor.--Each health care facility or State     <--
     8  GOVERNMENTAL correctional facility shall return to the vendor     <--
     9  pharmacy, for subsequent repackaging and redistribution by that
    10  vendor pharmacy to that health care facility or State             <--
    11  GOVERNMENTAL correctional facility, drug products that have       <--
    12  already been repackaged and redistributed pursuant to subsection
    13  (a) if:
    14         (1)  such drug products meet all of the requirements for
    15     initial repackaging found in subsection (a);
    16         (2)  the date on which the drug product was last
    17     repackaged, the drug product's lot number and the drug
    18     product's expiration date are indicated clearly on the
    19     package of such repackaged drug;
    20         (3)  90 days or fewer have elapsed from the date of
    21     initial repackaging of such drug product; and
    22         (4)  a repackaging log is maintained by the pharmacy in
    23     the case of drug products repackaged in advance of immediate
    24     needs.
    25     (c)  Exception.--No drug products dispensed in a bulk-
    26  dispensing container, including bottles, may be returned to
    27  vendor pharmacy for redistribution.
    28     (d)  Consent not required.--The consent of the individual for
    29  whom the unused drugs were originally prescribed shall not be
    30  required for reuse and redistribution.
    20070H0185B1529                  - 3 -     

     1     (e)  Rebate.--Nothing in this section shall require a
     2  pharmaceutical manufacturer to provide a rebate based on the
     3  reuse and redistribution of any unused drug as authorized in
     4  subsections (a) and (b).
     5     (f)  Department action.--The appropriate department shall
     6  implement policies to provide reimbursement for the return of
     7  unused drug products to the vendor pharmacy from which such drug
     8  products were purchased.
     9     (g)  Fees.--A fee of not more than 15% of the maximum
    10  wholesale price plus a crediting fee shall be provided to the
    11  vendor pharmacy by the health care facility receiving
    12  prepackaged drugs for the return of unused drug products.
    13     (h)  Limitation of liability.--No pharmaceutical
    14  manufacturers shall be held liable for any claim or injury
    15  arising from the transfer of any prescription drug pursuant to
    16  the provisions of this section, including, but not limited to,
    17  liability for failure to transfer or communicate product or
    18  consumer information regarding the transferred drug, as well as
    19  the expiration date of the transferred drug.
    20     (i)  Regulations.--The Department of Health, the Department
    21  of Corrections and the State Board of Pharmacy shall promulgate
    22  regulations to carry out the provisions of this act, including
    23  governing:
    24         (1)  the repackaging and labeling of drug products
    25     returned pursuant to subsections (a) and (b); and
    26         (2)  procedures for the return of unused products to the
    27     vendor pharmacy from which such drug products were purchased.
    28     (j)  Federal law.--All provisions of this act shall be in
    29  compliance with section 1171(4) of the Social Security Act (49
    30  Stat. 620, 42 U.S.C. § 1320d(4)).
    20070H0185B1529                  - 4 -     

     1  Section 4.  Effective date.
     2     This act shall take effect in 60 days.



















    L18L35JS/20070H0185B1529         - 5 -